Payment overview · 2025
General Payments
$381.94
13 reported records · 6 companies
Healthcare provider profile · identity verified
Richard J Ruffing, MD
Allopathic & Osteopathic Physicians|Family Medicine · GAFFNEY, SC · NPI 1689628646
Verified facts
What the public records show
CMS Open Payments records show Richard J Ruffing, MD received $381.94 in general payments during 2025 across 13 reported records.
Exact Sciences Corporation accounted for 46.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $177.00 | 46.3% | 5 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $74.61 | 19.5% | 3 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $50.62 | 13.2% | 2 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $31.34 | 8.2% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $31.14 | 8.2% | 1 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $17.23 | 4.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $381.94 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $177.00 | 5 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $74.61 | 3 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $50.62 | 2 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $31.34 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $31.34 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $31.14 | 1 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $17.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1067 | 161 |
| Atorvastatin Calcium | Atorvastatin Calcium | 542 | 158 |
| Amlodipine Besylate | Amlodipine Besylate | 430 | 126 |
| Omeprazole | Omeprazole | 408 | 121 |
| Gabapentin | Gabapentin | 360 | 98 |
| Metoprolol Succinate | Metoprolol Succinate | 356 | 108 |
| Tramadol Hcl | Tramadol Hcl | 322 | 78 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 276 | 80 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 248 | 73 |
| Lisinopril | Lisinopril | 235 | 84 |
| Furosemide | Furosemide | 226 | 69 |
| Amitriptyline Hcl | Amitriptyline Hcl | 221 | 61 |
| Metformin Hcl | Metformin Hcl | 217 | 57 |
| Pantoprazole Sodium | Pantoprazole Sodium | 203 | 64 |
| Tizanidine Hcl | Tizanidine Hcl | 199 | 89 |
| Lorazepam | Lorazepam | 191 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 174 | 58 |
| Levothyroxine Sodium | Levothyroxine Sodium | 173 | 49 |
| Potassium Chloride | Potassium Chloride | 167 | 52 |
| Glipizide | Glipizide | 164 | 44 |
| Azithromycin | Azithromycin | 153 | 120 |
| Clonazepam | Clonazepam | 149 | 25 |
| Prednisone | Prednisone | 149 | 100 |
| Trazodone Hcl | Trazodone Hcl | 141 | 37 |
| Amoxicillin | Amoxicillin | 139 | 102 |
| Losartan Potassium | Losartan Potassium | 138 | 41 |
| Pregabalin | Pregabalin | 137 | 27 |
| Eliquis | Apixaban | 133 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 130 | 43 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 129 | 34 |
| Alprazolam | Alprazolam | 128 | 19 |
| Carvedilol | Carvedilol | 127 | 44 |
| Clopidogrel | Clopidogrel Bisulfate | 127 | 42 |
| Spironolactone | Spironolactone | 121 | 39 |
| Glimepiride | Glimepiride | 113 | 33 |
| Doxepin Hcl | Doxepin Hcl | 110 | 38 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 109 | 20 |
| Ozempic | Semaglutide | 107 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 99 | 50 |
| Sertraline Hcl | Sertraline Hcl | 99 | 30 |
| Diclofenac Sodium | Diclofenac Sodium | 97 | 43 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 97 | 53 |
| Ibuprofen | Ibuprofen | 90 | 26 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 89 | 27 |
| Nortriptyline Hcl | Nortriptyline Hcl | 88 | 32 |
| Diazepam | Diazepam | 84 | 15 |
| Metformin Hcl Er | Metformin Hcl | 84 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 82 | 28 |
| Allopurinol | Allopurinol | 80 | 25 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 78 | 56 |
| Fluoxetine Hcl | Fluoxetine Hcl | 76 | 17 |
| Jardiance | Empagliflozin | 75 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | 24 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 65 | 19 |
| Simvastatin | Simvastatin | 64 | 21 |
| Meloxicam | Meloxicam | 60 | 25 |
| Fluconazole | Fluconazole | 57 | 45 |
| Ibandronate Sodium | Ibandronate Sodium | 57 | 12 |
| Promethazine Hcl | Promethazine Hcl | 55 | 17 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 53 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 52 | 17 |
| Buspirone Hcl | Buspirone Hcl | 50 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 50 | 16 |
| Alendronate Sodium | Alendronate Sodium | 49 | 13 |
| Estradiol | Estradiol | 48 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 47 | 12 |
| Montelukast Sodium | Montelukast Sodium | 46 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 46 | suppressed |
| Xarelto | Rivaroxaban | 44 | suppressed |
| Naproxen | Naproxen | 43 | 17 |
| Sucralfate | Sucralfate | 41 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 39 | 15 |
| Warfarin Sodium | Warfarin Sodium | 39 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 37 | suppressed |
| Chlorthalidone | Chlorthalidone | 37 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 36 | 31 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | 16 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 35 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 35 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 34 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 24 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 33 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 33 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 33 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Celecoxib | Celecoxib | 31 | suppressed |
| Glipizide Er | Glipizide | 31 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 29 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | 14 |
| Mirtazapine | Mirtazapine | 28 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 27 | 18 |
| Famotidine | Famotidine | 27 | 11 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 27 | 11 |
| Venlafaxine Hcl | Venlafaxine Hcl | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | 15 |
| Bumetanide | Bumetanide | 23 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 22 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Ursodiol | Ursodiol | 22 | suppressed |
| Lubiprostone | Lubiprostone | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 19 |
| Finasteride | Finasteride | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | 16 |
| Olanzapine | Olanzapine | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Febuxostat | Febuxostat | 19 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 19 | suppressed |
| Atenolol | Atenolol | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 18 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Colchicine | Colchicine | 17 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Ezetimibe | Ezetimibe | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Insulin Lispro Protamine Mix | Insulin Lispro Protamin/Lispro | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 14 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 14 | suppressed |
| Indapamide | Indapamide | 14 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $381.94 · 13 records | Exact Sciences Corporation | CT THROMBECTOMY SYSTEM KIT, Dexcom G6 Transmitter, EVENITY, FLOWTRIEVER CATHETER, S, FREESTYLE LIBRE 3, INSPIRE, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error